Overview

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Allopurinol
Febuxostat